Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.8
1.44 %
$ 937 M
Market Cap
-16.26
P/E
EOLS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity EOLS - Evolus, Inc.
189 M
LAST VALUE
66.26%
2 YEAR CAGR
48.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR